Table 2 Adverse effects of sirolimus treatment
From: mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Adverse effects (AEs) | All | % Patient with AEs | Grade 3–4 |
|---|---|---|---|
Diarrhea | 5 | 20.8 | 0 |
Fatigue | 3 | 12.5 | 0 |
Headache | 9 | 37.5 | 0 |
Nausea | 8 | 33.3 | 0 |
Pruritus | 2 | 8.3 | 0 |
Rash | 2 | 8.3 | 0 |
Stomach pain | 3 | 12.5 | 0 |